Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    "Pterygium of the conjunctiva and cornea"
Hide Display Options

Display Options

Study Details
Participant Details
Rank Status Study
1 Completed Randomized Controlled Trial of Subconjunctival Bevacizumab Injection in Impending Recurrent Pterygium
Condition: Pterygium of the Conjunctiva and Cornea
Interventions: Drug: Fluorometholone;   Drug: Bevacizumab

Indicates status has not been verified in more than two years